Efficacy and Safety of Tenofovir Disoproxil Fumarate Plus Lamivudine Plus Efavirenz Regimen as First-line Antiretroviral Therapy for ART-naive Chinese Patients With HIV-1 Infection
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Efavirenz (Primary) ; Lamivudine (Primary) ; Tenofovir disoproxil fumarate (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 27 Apr 2016 Status changed from not yet recruiting to recruiting.
- 27 Apr 2016 Results of secondary analysis (n=134) published in the AIDS.
- 08 May 2013 New trial record